Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05000190 · ClinicalTrials.gov registry record · NA
Acute and Chronic Effect of 250 mg Citicoline Consumption on Attention in Adults: A Randomized Trial
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT05000190 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 104 participants.
The verdict
NCT05000190, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The primary study objectives are to test whether among a sample of healthy adults consuming: (1) a single capsule containing 250 mg citicoline has an effect on attentional performance 1, 2 and 3 h post-dose compared to placebo (acute effect), and (2) capsule containing 250 mg citicoline per day for 28 consecutive days has an effect on attentional performance compared to placebo (chronic effect).
Interventions
- OTHER Placebo capsule
- DIETARY_SUPPLEMENT Active capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05000190
The ClinicalTrials.gov registry entry for NCT05000190 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo capsule is the first listed.
NCT05000190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05000190 about?
NCT05000190 is a clinical study titled "Acute and Chronic Effect of 250 mg Citicoline Consumption on Attention in Adults: A Randomized Trial". The primary study objectives are to test whether among a sample of healthy adults consuming: (1) a single capsule containing 250 mg citicoline has an effect on attentional performance 1, 2 and 3 h post-dose compared to placebo (acute effect), and (2) capsule containing 250 mg citicoline per day for ...
What is the current status of trial NCT05000190?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2021-09-13. Estimated completion is 2022-07-19.
What interventions are being tested in trial NCT05000190?
The interventions under investigation include: Placebo capsule (OTHER), Active capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05000190?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.